Vulnerability Details : CVE-2022-34831
An issue was discovered in Keyfactor PrimeKey EJBCA before 7.9.0, related to possible inconsistencies in DNS identifiers submitted in an ACME order and the corresponding CSR submitted during finalization. During the ACME enrollment process, an order is submitted containing an identifier for one or multiple dnsNames. These are validated properly in the ACME challenge. However, if the validation passes, a non-compliant client can include additional dnsNames the CSR sent to the finalize endpoint, resulting in EJBCA issuing a certificate including the identifiers that were not validated. This occurs even if the certificate profile is configured to not allow a DN override by the CSR.
Products affected by CVE-2022-34831
- cpe:2.3:a:primekey:ejbca:*:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2022-34831
0.15%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 50 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2022-34831
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
9.8
|
CRITICAL | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H |
3.9
|
5.9
|
NIST |
CWE ids for CVE-2022-34831
-
The product does not validate, or incorrectly validates, a certificate.Assigned by: nvd@nist.gov (Primary)
References for CVE-2022-34831
-
https://www.primekey.com/products/ejbca-enterprise/
EJBCA PKI - Enterprise PKI - Leading security solutions from PrimeKeyProduct;Vendor Advisory
-
https://support.keyfactor.com/s/detail/a6x1Q000000CwC5QAK
News Article: EJBCA Security Advisory - ACME issuance for non-validated domainsVendor Advisory
Jump to